» Articles » PMID: 16005017

A Mutation in the N-terminus of Troponin I That is Associated with Hypertrophic Cardiomyopathy Affects the Ca(2+)-sensitivity, Phosphorylation Kinetics and Proteolytic Susceptibility of Troponin

Overview
Date 2005 Jul 12
PMID 16005017
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The first human cardiac troponin I (hcTnI) mutation in the N-terminal 32 residue region, R21C (arginine residue number 21 mutated to cysteine), which has been linked to hypertrophic cardiomyopathy (HCM), has recently been reported. The effect of this mutation on the physiological function of hcTnI was investigated. Human cTnI R21C (in the absence or presence of troponin T and troponin C) was phosphorylated by protein kinase A (PKA) at a significantly slower rate than wild-type hcTnI. In skinned fiber studies, the TnI R21C mutant showed a large increase in Ca(2+)-sensitivity of force development when compared to wild-type TnI (DeltapCa(50)=0.33). Phosphorylation of skinned fibers containing TnI R21C by PKA resulted in a significantly smaller decrease in the Ca(2+)-sensitivity of force development when compared to phosphorylation of fibers containing wild-type TnI. The decreased sensitivity of TnI R21C to PKA is most likely due to a decreased ability of PKA to phosphorylate this TnI rather than conformational problems within this TnI. In addition, skinned fibers were found to contain an endogenous kinase that is capable of phosphorylating wild-type TnI. However, the endogenous kinase activity did not affect the Ca(2+)-sensitivity of force development, the Hill coefficient or maximal force of these skinned fibers. Actomyosin ATPase assays showed that the R21C mutation did not affect the inhibitory properties of TnI or the maximal ATPase activity. TnI R21C was also found to be more susceptible to proteolysis by calpain II than wild-type TnI. These results suggest that this R21C mutation in TnI affects the Ca(2+)-sensitizing effect of Tn, the ability of TnI to be readily phosphorylated by PKA and the stability of TnI to calpain. The results also suggest that the N-terminal region may have important roles such as modulating the Ca(2+)-sensitivity of force-development.

Citing Articles

Focus on cardiac troponin complex: From gene expression to cardiomyopathy.

Ragusa R, Caselli C Genes Dis. 2024; 11(6):101263.

PMID: 39211905 PMC: 11357864. DOI: 10.1016/j.gendis.2024.101263.


Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies.

Barefield D, Alvarez-Arce A, Araujo K Curr Cardiol Rep. 2023; 25(6):473-484.

PMID: 37060436 PMC: 11141690. DOI: 10.1007/s11886-023-01876-9.


Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.

van Opbergen C, Bagwan N, Maurya S, Kim J, Smith A, Blackwell D Circulation. 2022; 145(19):1480-1496.

PMID: 35491884 PMC: 9086182. DOI: 10.1161/CIRCULATIONAHA.121.057757.


CalTrack: High-Throughput Automated Calcium Transient Analysis in Cardiomyocytes.

Psaras Y, Margara F, Cicconet M, Sparrow A, Repetti G, Schmid M Circ Res. 2021; 129(2):326-341.

PMID: 34018815 PMC: 8260473. DOI: 10.1161/CIRCRESAHA.121.318868.


Mechanosignaling pathways alter muscle structure and function by post-translational modification of existing sarcomeric proteins to optimize energy usage.

Russell B, Solis C J Muscle Res Cell Motil. 2021; 42(2):367-380.

PMID: 33595762 PMC: 8338793. DOI: 10.1007/s10974-021-09596-9.